drugset / Trial / NCT02639377

Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis

NCT02639377

Phase 2 Completed 29 enrolled Federal University of Rio Grande do Norte
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to analyze the efficacy of 0.12% chlorhexidine gluconate as a chemical adjuvant for the treatment of peri-implant mucositis in single implants compared with homologous teeth with gingivitis, in a non-surgical treatment protocol with a six-month follow-up.

Timeline

Start
2012-10
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate Other / unclassified 0.12 %
Subject Chlorhexidine gluconate Other / unclassified 15 ml

Indications